Insider sold ~$6.31M of ROIV shares in the open market

Past results only. Not a forecast.

Record ID

0001193125-25-325343

Filed / recorded

Dec 19, 2025, 5:41 AM UTC

Added to OQRO

Oct 6, 2026, 8:46 PM UTC

Parser

form4-xml-v2

Data quality

Verified: identifiers matched exactly

Issuer

Roivant Sciences Ltd.

Issuer CIK

1635088

Ticker

ROIV

Reporting person

QVT Financial LP

Relationship

Other

Security

Common Shares

Table

Non-derivative (Table I)

Transaction date

Dec 16, 2025

Transaction code

S

Shares / units

275,000

Price per share

$22.93

Acquired / disposed

Disposed (D)

Shares owned after

17,772,727

Ownership form

Indirect — Held by QVT Financial Investment Cayman Ltd.

Amendment

No

1. Aggregately, following the transactions described above, QVT Financial LP ("QVT"), a Delaware limited partnership, may be deemed to be the beneficial owner of 26,387,021 Common Shares, consisting of the Common Shares owned by QVT P&E Roiv Hldgs Ltd. ("QVT P&E"), QVT Deferred Compensation Holdings Ltd ("QVT DCH") and QVT Financial Investment Cayman Ltd. ("QVT FIC"). QVT Financial GP LLC, a Delaware limited liability company, is the general partner of QVT and may be deemed to beneficially own the same number of Common Shares reported by QVT.
2. QVT provides certain investment advisory services for, and thereby may be deemed to beneficially own the Common Shares held by, QVT P&E, QVT DCH and QVT FIC. QVT disclaims beneficial ownership of such Common Shares, except to the extent of any pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.